114 related articles for article (PubMed ID: 16787411)
21. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
[TBL] [Abstract][Full Text] [Related]
22. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
23. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Villarán RF; Tomás-Camardiel M; de Pablos RM; Santiago M; Herrera AJ; Navarro A; Machado A; Cano J
Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658
[TBL] [Abstract][Full Text] [Related]
24. Ultrastructural characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced cell death in embryonic dopaminergic neurons.
Dorsey DA; Mascó DH; Dikranian K; Hyrc K; Masciotra L; Faddis B; Soriano M; Gru AA; Goldberg MP; de Erausquin GA
Apoptosis; 2006 Apr; 11(4):535-44. PubMed ID: 16532276
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
26. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease.
Lee SY; Moon Y; Hee Choi D; Jin Choi H; Hwang O
Neurobiol Dis; 2007 Jan; 25(1):112-20. PubMed ID: 17049260
[TBL] [Abstract][Full Text] [Related]
27. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.
Leak RK; Liou AK; Zigmond MJ
J Neurochem; 2006 Nov; 99(4):1151-63. PubMed ID: 16956375
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress to dopaminergic neurons as models of Parkinson's disease.
Gille G; Hung ST; Reichmann H; Rausch WD
Ann N Y Acad Sci; 2004 Jun; 1018():533-40. PubMed ID: 15240412
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
Liang CL; Wang TT; Luby-Phelps K; German DC
Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
[TBL] [Abstract][Full Text] [Related]
30. Reactive oxygen species-induced cell death of rat primary astrocytes through mitochondria-mediated mechanism.
Wang CC; Fang KM; Yang CS; Tzeng SF
J Cell Biochem; 2009 Aug; 107(5):933-43. PubMed ID: 19459161
[TBL] [Abstract][Full Text] [Related]
31. 3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor.
Iravani MM; Haddon CO; Rose S; Jenner P
Brain Res; 2006 Jan; 1067(1):256-62. PubMed ID: 16388785
[TBL] [Abstract][Full Text] [Related]
32. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.
Fuentes P; Paris I; Nassif M; Caviedes P; Segura-Aguilar J
Chem Res Toxicol; 2007 May; 20(5):776-83. PubMed ID: 17425337
[TBL] [Abstract][Full Text] [Related]
34. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
36. Persistent mitochondrial dysfunction and oxidative stress hinder neuronal cell recovery from reversible proteasome inhibition.
Papa L; Rockwell P
Apoptosis; 2008 Apr; 13(4):588-99. PubMed ID: 18299995
[TBL] [Abstract][Full Text] [Related]
37. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death.
Papa L; Gomes E; Rockwell P
Apoptosis; 2007 Aug; 12(8):1389-405. PubMed ID: 17415663
[TBL] [Abstract][Full Text] [Related]
38. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
[TBL] [Abstract][Full Text] [Related]
39. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease.
Thomas T; Timmer M; Cesnulevicius K; Hitti E; Kotlyarov A; Gaestel M
J Neurochem; 2008 Jun; 105(5):2039-52. PubMed ID: 18298661
[TBL] [Abstract][Full Text] [Related]
40. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
